Literature DB >> 24281057

Haematological cancer: Richter's transformation in CLL-a distinct lymphoma.

Preetesh Jain1, Ken H Young2.   

Abstract

A landmark study has delineated and identified the genetic pathways that drive the natural course of chronic lymphocytic leukaemia (CLL) B cells into Richter’s transformation. CLL-related Richter’s transformation is a distinct lymphoma, and poses various questions about B-cell ontogeny and relevance of B cell receptor signalling inhibitors.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24281057     DOI： 10.1038/nrclinonc.2013.229

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  10 in total

1.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Marco Fangazio; Sara Monti; Mariangela Greco; Carmela Ciardullo; Rosella Famà; Stefania Cresta; Alessio Bruscaggin; Luca Laurenti; Maurizio Martini; Pellegrino Musto; Francesco Forconi; Roberto Marasca; Luigi M Larocca; Robin Foà; Gianluca Gaidano
Journal:  Br J Haematol       Date:  2012-05-10       Impact factor: 6.998

3.  Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.

Authors:  Davide Rossi; Michaela Cerri; Daniela Capello; Clara Deambrogi; Francesca Maria Rossi; Antonella Zucchetto; Lorenzo De Paoli; Stefania Cresta; Silvia Rasi; Valeria Spina; Silvia Franceschetti; Monia Lunghi; Chiara Vendramin; Riccardo Bomben; Antonio Ramponi; Guido Monga; Annarita Conconi; Corrado Magnani; Valter Gattei; Gianluca Gaidano
Journal:  Br J Haematol       Date:  2008-05-19       Impact factor: 6.998

4.  The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.

Authors:  Davide Rossi; Valeria Spina; Clara Deambrogi; Silvia Rasi; Luca Laurenti; Kostas Stamatopoulos; Luca Arcaini; Marco Lucioni; Gabrielle B Rocque; Zijun Y Xu-Monette; Carlo Visco; Julie Chang; Ekaterina Chigrinova; Francesco Forconi; Roberto Marasca; Caroline Besson; Theodora Papadaki; Marco Paulli; Luigi M Larocca; Stefano A Pileri; Valter Gattei; Francesco Bertoni; Robin Foà; Ken H Young; Gianluca Gaidano
Journal:  Blood       Date:  2011-01-25       Impact factor: 22.113

5.  Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

Authors:  Ekaterina Chigrinova; Andrea Rinaldi; Ivo Kwee; Davide Rossi; Paola M V Rancoita; Jonathan C Strefford; David Oscier; Kostas Stamatopoulos; Theodora Papadaki; Francoise Berger; Ken H Young; Fiona Murray; Richard Rosenquist; Timothy C Greiner; Wing C Chan; Ester M Orlandi; Marco Lucioni; Roberto Marasca; Giorgio Inghirami; Marco Ladetto; Francesco Forconi; Sergio Cogliatti; Hana Votavova; Steven H Swerdlow; Stephan Stilgenbauer; Miguel A Piris; Andras Matolcsy; Dominic Spagnolo; Eugene Nikitin; Alberto Zamò; Valter Gattei; Govind Bhagat; German Ott; Emanuele Zucca; Gianluca Gaidano; Francesco Bertoni
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

6.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

7.  Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

Authors:  Apostolia-Maria Tsimberidou; Susan O'Brien; Hagop M Kantarjian; Charles Koller; Fredrick B Hagemeister; Luis Fayad; Susan Lerner; Carlos E Bueso-Ramos; Michael J Keating
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

8.  Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

Authors:  Yoshikane Kikushige; Fumihiko Ishikawa; Toshihiro Miyamoto; Takahiro Shima; Shingo Urata; Goichi Yoshimoto; Yasuo Mori; Tadafumi Iino; Takuji Yamauchi; Tetsuya Eto; Hiroaki Niiro; Hiromi Iwasaki; Katsuto Takenaka; Koichi Akashi
Journal:  Cancer Cell       Date:  2011-08-16       Impact factor: 31.743

9.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

10.  Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.

Authors:  Giulia Fabbri; Hossein Khiabanian; Antony B Holmes; Jiguang Wang; Monica Messina; Charles G Mullighan; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2013-10-14       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.